Click here to view the printer friendly version of this press release
NEW YORK, N.Y., -- Manhattan Scientifics (OTC BB: MHTX) today issued a letter from the company CEO, Manny Tsoupanarias.
I hope that everyone has enjoyed a wonderful summer and as many of you may have read in our recent press release, our common shares are now quoted on the OTC:BB. We worked very hard to get back to this trading system because it was in the best interests of our company and our shareholders. We will continue to work hard to create shareholder value.
We are currently working with potential customers and partners to validate and commercialize Manhattan Scientifics’ nano-structured metal technology. As we continue to advance and meet our goals of commercializing this technology, we will continue to leverage our core skills in the nano-structuring of metals and advanced process technologies that can be translated into a broad range of products and applications with the possibility of generating near-term revenues for our company.
I would also like to thank all our shareholders for their continued support and patience.
Manny Tsoupanarias, CEO
Manhattan Scientifics